Structure Therapeutics (GPCR) Other Non-Current Assets (2022 - 2026)

Structure Therapeutics (GPCR) recorded quarterly Other Non-Current Assets of $5.6 million in Q1 2026, up 674.76% quarter-over-quarter from $717000.0 in Q4 2025, and down 8.87% on a YoY basis from $6.1 million in Q1 2025.

Structure Therapeutics (GPCR) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Structure Therapeutics' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $5.6 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets fell 8.87% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (down 8.87% YoY), while the FY2025 annual figure was $717000.0, down 85.96% from the prior year.
  • Other Non-Current Assets was $5.6 million for Q1 2026 at Structure Therapeutics, up from $717000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.6 million in Q3 2025 to a low of $38000.0 in Q2 2023.
  • Historically, Other Non-Current Assets has averaged $2.7 million across 5 years, with a median of $1.8 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets plunged 98.7% in 2023, then soared 12870.21% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.5 million in 2022, then slumped by 98.7% to $45000.0 in 2023, then jumped by 11246.67% to $5.1 million in 2024, then sank by 85.96% to $717000.0 in 2025, then soared by 674.76% to $5.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $5.6 million (Q1 2026), $717000.0 (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 60,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.26 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Structure Therapeutics 9.35 Bn 9.35 Bn - 5.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.56 Mn
Dec 31, 2025 717,000.00
Sep 30, 2025 6.60 Mn
Jun 30, 2025 6.20 Mn
Mar 31, 2025 6.10 Mn
Dec 31, 2024 5.11 Mn
Sep 30, 2024 1.82 Mn
Jun 30, 2024 1.83 Mn
Mar 31, 2024 47,000.00
Dec 31, 2023 45,000.00
Sep 30, 2023 350,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 59,000.00
Dec 31, 2022 3.46 Mn